BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38589358)

  • 1. Integration of pathologic characteristics, genetic risk and lifestyle exposure for colorectal cancer survival assessment.
    Xin J; Gu D; Li S; Qian S; Cheng Y; Shao W; Ben S; Chen S; Zhu L; Jin M; Chen K; Hu Z; Zhang Z; Du M; Shen H; Wang M
    Nat Commun; 2024 Apr; 15(1):3042. PubMed ID: 38589358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk assessment for colorectal cancer via polygenic risk score and lifestyle exposure: a large-scale association study of East Asian and European populations.
    Xin J; Du M; Gu D; Jiang K; Wang M; Jin M; Hu Y; Ben S; Chen S; Shao W; Li S; Chu H; Zhu L; Li C; Chen K; Ding K; Zhang Z; Shen H; Wang M
    Genome Med; 2023 Jan; 15(1):4. PubMed ID: 36694225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyses of 7,635 Patients with Colorectal Cancer Using Independent Training and Validation Cohorts Show That rs9929218 in CDH1 Is a Prognostic Marker of Survival.
    Smith CG; Fisher D; Harris R; Maughan TS; Phipps AI; Richman S; Seymour M; Tomlinson I; Rosmarin D; Kerr D; Chan AT; Peters U; Newcomb PA; Idziaszczyk S; West H; Meade A; Kaplan R; Cheadle JP
    Clin Cancer Res; 2015 Aug; 21(15):3453-61. PubMed ID: 25873087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide association study identifies tumor anatomical site-specific risk variants for colorectal cancer survival.
    Labadie JD; Savas S; Harrison TA; Banbury B; Huang Y; Buchanan DD; Campbell PT; Gallinger SJ; Giles GG; Gunter MJ; Hoffmeister M; Hsu L; Jenkins MA; Lin Y; Ogino S; Phipps AI; Slattery ML; Steinfelder RS; Sun W; Van Guelpen B; Hua X; Figuieredo JC; Pai RK; Nassir R; Qi L; Chan AT; Peters U; Newcomb PA
    Sci Rep; 2022 Jan; 12(1):127. PubMed ID: 34996992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating genome-wide polygenic risk scores and non-genetic risk to predict colorectal cancer diagnosis using UK Biobank data: population based cohort study.
    Briggs SEW; Law P; East JE; Wordsworth S; Dunlop M; Houlston R; Hippisley-Cox J; Tomlinson I
    BMJ; 2022 Nov; 379():e071707. PubMed ID: 36351667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
    Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
    Elife; 2023 Mar; 12():. PubMed ID: 36971353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer.
    Kandimalla R; Gao F; Matsuyama T; Ishikawa T; Uetake H; Takahashi N; Yamada Y; Becerra C; Kopetz S; Wang X; Goel A
    Clin Cancer Res; 2018 Aug; 24(16):3867-3877. PubMed ID: 29514841
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic risk, incident gastric cancer, and healthy lifestyle: a meta-analysis of genome-wide association studies and prospective cohort study.
    Jin G; Lv J; Yang M; Wang M; Zhu M; Wang T; Yan C; Yu C; Ding Y; Li G; Ren C; Ni J; Zhang R; Guo Y; Bian Z; Zheng Y; Zhang N; Jiang Y; Chen J; Wang Y; Xu D; Zheng H; Yang L; Chen Y; Walters R; Millwood IY; Dai J; Ma H; Chen K; Chen Z; Hu Z; Wei Q; Shen H; Li L
    Lancet Oncol; 2020 Oct; 21(10):1378-1386. PubMed ID: 33002439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort study.
    Grothey A; Flick ED; Cohn AL; Bekaii-Saab TS; Bendell JC; Kozloff M; Roach N; Mun Y; Fish S; Hurwitz HI
    Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):726-34. PubMed ID: 24830357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic evaluation of polygenic risk score underlying pan-cancer analysis: evidence from two large-scale cohorts.
    Xin J; Jiang X; Li H; Chen S; Zhang Z; Wang M; Gu D; Du M; Christiani DC
    EBioMedicine; 2023 Mar; 89():104454. PubMed ID: 36739632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival marker genes of colorectal cancer derived from consistent transcriptomic profiling.
    Martinez-Romero J; Bueno-Fortes S; Martín-Merino M; Ramirez de Molina A; De Las Rivas J
    BMC Genomics; 2018 Dec; 19(Suppl 8):857. PubMed ID: 30537927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined associations of a healthy lifestyle and body mass index with colorectal cancer recurrence and survival: a cohort study.
    Barot S; Rantanen P; Nordenvall C; Lindforss U; Hallqvist Everhov Å; Larsson SC; Lindblom A; Liljegren A
    Cancer Causes Control; 2024 Feb; 35(2):367-376. PubMed ID: 37782382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diet- and Lifestyle-Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB 89803/Alliance).
    Cheng E; Ou FS; Ma C; Spiegelman D; Zhang S; Zhou X; Bainter TM; Saltz LB; Niedzwiecki D; Mayer RJ; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Giovannucci EL; Van Blarigan EL; Brown JC; Ng K; Gross CP; Meyerhardt JA; Fuchs CS
    J Clin Oncol; 2022 Mar; 40(7):740-751. PubMed ID: 34995084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective cohort study of the influence of lifestyle factors on the survival of patients undergoing surgery for colorectal cancer.
    Alexander D; Allardice GM; Moug SJ; Morrison DS
    Colorectal Dis; 2017 Jun; 19(6):544-550. PubMed ID: 28027419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathologic prognostic factors in resected colorectal lung metastases.
    Shiono S; Ishii G; Nagai K; Yoshida J; Nishimura M; Murata Y; Tsuta K; Nishiwaki Y; Kodama T; Ochiai A
    Ann Thorac Surg; 2005 Jan; 79(1):278-82; discussion 283. PubMed ID: 15620957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined impact of healthy lifestyle factors on colorectal cancer: a large European cohort study.
    Aleksandrova K; Pischon T; Jenab M; Bueno-de-Mesquita HB; Fedirko V; Norat T; Romaguera D; Knüppel S; Boutron-Ruault MC; Dossus L; Dartois L; Kaaks R; Li K; Tjønneland A; Overvad K; Quirós JR; Buckland G; Sánchez MJ; Dorronsoro M; Chirlaque MD; Barricarte A; Khaw KT; Wareham NJ; Bradbury KE; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Krogh V; Tumino R; Naccarati A; Panico S; Siersema PD; Peeters PH; Ljuslinder I; Johansson I; Ericson U; Ohlsson B; Weiderpass E; Skeie G; Borch KB; Rinaldi S; Romieu I; Kong J; Gunter MJ; Ward HA; Riboli E; Boeing H
    BMC Med; 2014 Oct; 12():168. PubMed ID: 25319089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline INDELs and CNVs in a cohort of colorectal cancer patients: their characteristics, associations with relapse-free survival time, and potential time-varying effects on the risk of relapse.
    Werdyani S; Yu Y; Skardasi G; Xu J; Shestopaloff K; Xu W; Dicks E; Green J; Parfrey P; Yilmaz YE; Savas S
    Cancer Med; 2017 Jun; 6(6):1220-1232. PubMed ID: 28544645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival rates and predictors of survival among colorectal cancer patients in a Malaysian tertiary hospital.
    Magaji BA; Moy FM; Roslani AC; Law CW
    BMC Cancer; 2017 May; 17(1):339. PubMed ID: 28521746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical risk score to predict 3-, 5- and 10-year survival in patients undergoing surgery for Dukes B colorectal cancer.
    McMillan DC; McArdle CS; Morrison DS
    Br J Cancer; 2010 Sep; 103(7):970-4. PubMed ID: 20808311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and prognostic association in stage IV colorectal cancer patients treated with chemotherapy in Bangladesh.
    Shuayb M; Mehedi Hasan M; Hoque MR; Mushtaq Hussain Q; Begum R; Reza MS
    Jpn J Clin Oncol; 2021 Apr; 51(4):552-559. PubMed ID: 33341898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.